Neurovascular Stents Market Analysis | Europe | 2017-2023 | MedCore

Neurovascular Stents Market Analysis | Europe | 2017-2023 | MedCore

0

There are two main types of neurovascular stents currently on the market, the traditional stent and the flow diverter stent. They are both used as treatments for cerebral aneurysms.
Traditional neurovascular stents are small, flexible, tube-like devices used for stabilizing detachable coils within an aneurysm. They serve to block off the aneurysm and to prevent coils from slipping back into the main blood vessel. These stents are also used to treat intracranial stenosis by opening blocked arteries.
These stents are delivered in reduced tube structures for easier navigation and delivery through the narrow intracranial vessels. As brain arteries are more fragile than carotid arteries, a self-expanding stent that gently opens to the desired vessel diameter is generally used. Self-expandable stents carry a lower risk of dissection or vessel rupture when compared to the balloon-expandable stents.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 12/1/2016
  • Pages: 288
  • Type: MedCore

The total neurovascular stent market includes both traditional neurovascular stents and flow diversion stents. There will a slight decrease in market value of the neurovascular stent market due to price decreases from competitive pressure in the stent market and in other new medical devices for the treatment of aneurysms.

These stents are built with nitinol, which is an alloy made of roughly equal amounts of nickel and titanium. Nitinol is used for its shape memory and super elasticity. While the super elasticity of nitinol is superior to almost all other metals, there have been fatigue failures observed that either shift the stent or cause damage to the vessel, depending on the type of failure. Nickel is also toxic and carcinogenic, despite being an alloy, and there is a risk of it leeching into the blood of patients. This can be avoided by properly coating the stent to avoid direct blood to metal contact which is now standard practice. Stents are associated with a decrease in aneurysms recurrences but some studies have also found more dangerous complications than coiling alone. However, other studies have found comparable procedure related complications.

Segments Covered in This Market

  • Traditional Neurovascular Stent Market
  • Flow Diversion Stent Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the European Neurovascular Stent market, Medtronic was the leader, followed by Phenox and Balt. Medtronic’s traditional stent, the Solitaire™AB, received its CE mark in December 2007. It can be retrieved even when fully deployed, and also allows for multiple retrievals for adjustment and superior placement. Other companies analyzed include Terumo MicroVention, Stryker, and Codman & Shurtleff, Inc.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices – MedSuite

Learn More about these product types



The "Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link